Processa Pharmaceuticals Inc. (PCSA)
NASDAQ: PCSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
PCSA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $3.97M
- EPS (TTM)
- -$4.05
- Dividend yield
- None
- 52-week range
- 1.41 – 11.08
- Day range
- 1.41 – 1.49
- Volume / Avg
- 12.81K / 228.15K
- Beta
- —
- Shares outstanding
- 2.79M
- Next earnings
- Nov 5, 2026
52-week range
PCSA stock today
Processa Pharmaceuticals (PCSA) closed at $1.42 on Oct 7, down 5.96% (-$0.09), versus the S&P 500's 0.22% decline. Trading was light, with 12.81K shares changing hands, about 6% of the average daily volume. Shares are 87.2% below their 52-week high of $11.08 and 0.7% above the 52-week low of $1.41, near the bottom of the past year's range.
Processa Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$4.05), so its P/E ratio is not meaningful. Processa Pharmaceuticals's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Processa Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Earnings
Earnings history- Next report
- Nov 5, 2026
Processa Pharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ERNAErnexa Therapeutics Inc. | 2.39 | +6.94% | $3.90M | vs PCSA |
| GRIGRI Bio Inc. | 1.85 | -2.63% | $4.04M | vs PCSA |
| SXTP60 Degrees Pharmaceuticals Inc. | 1.10 | -0.90% | $3.87M | vs PCSA |
| JUNSJupiter Neurosciences Inc. | 2.84 | -0.70% | $3.74M | vs PCSA |
| SXTCChina SXT Pharmaceuticals Inc. Class A | 2.83 | +126.40% | $3.74M | vs PCSA |
| RDHLRedhill Biopharma Ltd. ADR | 0.474 | -2.07% | $4.21M | vs PCSA |
| EOCNEocene Ltd. | 3.46 | +2.91% | $3.69M | vs PCSA |
| HCWBHCW Biologics Inc. | 1.56 | -0.64% | $3.49M | vs PCSA |
Indexes, lists and sector
Processa Pharmaceuticals stock FAQ
What is Processa Pharmaceuticals's stock price today?
PCSA last traded at $1.42 as of Oct 7, 4:00 PM EDT, down 5.96% on the day. Prices are delayed at least 15 minutes.
When is Processa Pharmaceuticals's next earnings date?
Processa Pharmaceuticals is expected to report earnings on Thursday, November 5, 2026.
What is the PCSA 52-week high?
The 52-week high for PCSA is $11.08 and the 52-week low is $1.41. The stock is currently 87.2% below its high.